Bottom line
What is EPSKX's expense ratio?
EPSKX's expense ratio is 1.84%, or about $184 a year on every $10,000 invested. That is more expensive than 91% of global stock funds we track (median 0.95%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Feb 26, 2026
EPSKX fee table
| Net expense ratio | 1.84% |
|---|---|
| Gross expense ratio | 1.92% |
| Management fee | 0.7% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.22% |
| Fee waiver / reimbursement | -0.08% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What EPSKX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| EPSKX | $287 | $595 | $1,029 | $2,042 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.84% expense ratio costs roughly $94,800 in lost growth, versus about $52,800 for the median global stock fund (0.95%).